Severe immune‑related adverse events of immune checkpoint inhibitors for advanced non‑small cell lung cancer: a network meta‑analysis of randomized clinical trials. | 2022 | Cancer Immunology, Immunotherapy |
Efficacy and safety of first-line systemic therapy for metastatic renal cell carcinoma: a systematic review and network meta-analysis. | 2022 | European Urology Open Science |
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis. | 2022 | ESMO Open |
Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review. | 2022 | BMJ Open Ophthalmology |
The efficacy and safety of combined ipilimumab and nivolumab versus ipilimumab in patients with stage III/IV unresectable melanoma: a systematic review and meta‑analysis. | 2022 | Journal of Cancer Research and Therapeutics |
Best regimens for treating chemo-naïve incurable squamous non-small cell lung cancer with a programmed death-ligand 1 tumor proportion score of 1%–49%: a network meta-analysis. | 2022 | Thoracic Cancer |
Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis. | 2021 | Therapeutic Advances in Urology |
Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis. | 2021 | Cancer Cell International |
The best regimens for chemo-naïve incurable non-squamous non-small cell lung cancer with a programmed death-ligand 1, tumor proportion score 1–49%: a network meta-analysis. | 2021 | Translational Lung Cancer Research |
Comparative efficacy of treatments for brain metastases from non–small cell lung cancer without an EGFR-mutation/ALK-rearrangement: a systematic review and network meta-analysis. | 2021 | World Neurosurgery |
Immune-related adverse events associated with immune checkpoint inhibitors for advanced non-small cell lung cancer: a network meta-analysis of randomized clinical trials. | 2021 | Frontiers in Pharmacology |
Immune checkpoint inhibitor with or without radiotherapy in melanoma patients with brain metastases: a systematic review and meta-analysis. | 2021 | Korean Journal of Radiology |
Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: a systematic literature review and network meta-analysis. | 2021 | BMC Cancer |
Immune checkpoint inhibitors for first-line treatment of advanced non-small-cell lung cancer: a systematic review and network meta-analysis. | 2021 | Thoracic Cancer |
Chemotherapy in focus: a meta-analysis confronts immunotherapy in the treatment of advanced melanoma. | 2021 | Critical Reviews in Oncology/Hematology |
A living, interactive systematic review and network meta-analysis of first-line treatment of metastatic renal cell carcinoma. | 2021 | European Urology |
Prevalence of dermatological toxicities in patients with melanoma undergoing immunotherapy: systematic review and meta-analysis. | 2021 | PLoS One |
Selection of optimal first-line immuno-related therapy based on specific pathological characteristics for patients with advanced driver-gene wild-type non-small cell lung cancer: a systematic review and network meta-analysis. | 2021 | Therapeutic Advances in Medical Oncology |
Systematic review and meta‑analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti‑PD‑1 progression: a systematic review and meta‑analysis. | 2021 | Clinical and Translational Oncology |
Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer. | 2021 | The Cochrane Database of Systematic Reviews |
Economic evaluation of systemic treatments for advanced melanoma: a systematic review. | 2020 | Value in Health |
The risk ratio of immune-related colitis, hepatitis, and pancreatitis in patients with solid tumors caused by PD-1/PD-L1 inhibitors: a systematic review and meta-analysis. | 2020 | Frontiers in Oncology |
Immune checkpoint inhibitors and immune-related adverse events in patients with advanced melanoma. | 2020 | JAMA Network Open |
First-line treatments for advanced renal cell carcinoma with immune checkpoint inhibitors: systematic review, network meta-analysis and cost-effectiveness analysis. | 2020 | Therapeutic Advances in Medical Oncology |
Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review. | 2020 | Therapeutic Advances in Medical Oncology |
Targeted therapy for metastatic renal cell carcinoma. | 2020 | The Cochrane Database of Systematic Reviews |
Immune checkpoint inhibitors in advanced acral melanoma: a systematic review. | 2020 | Frontiers in Oncology |
Immunotherapy for metastatic renal cell carcinoma: a systematic review. | 2019 | Journal or Evidence-Based Medicine |
Role of immune checkpoint inhibitor-based therapies for metastatic renal cell carcinoma in the first-line setting: a Bayesian network analysis. | 2019 | EBioMedicine |
The differences in the safety and tolerability of immune checkpoint inhibitors as treatment for non–small cell lung cancer and melanoma: network meta-analysis and systematic review. | 2019 | Frontiers in Pharmacology |
Risk of immune-related pancreatitis in patients with solid tumors treated with immune checkpoint inhibitors: systematic assessment with meta-analysis. | 2018 | Journal of Immunology Research |
Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review. | 2018 | Melanoma Management |
Clinical and molecular characteristics associated with survival in advanced melanoma treated with checkpoint inhibitors. | 2018 | Journal of Oncology |
Efficacy and safety of ipilimumab plus chemotherapy for advanced lung cancer: a systematic review and meta-analysis. | 2018 | Journal of Cancer |
Checkpoint inhibitors for malignant melanoma: a systematic review and meta-analysis. | 2017 | Clinical, Cosmetic and Investigational Dermatology |
Immune checkpoint blockade for unresectable or metastatic uveal melanoma: a systematic review. | 2017 | Cancer Treatment Reviews |
Multiple treatment comparison of seven new drugs for patients with advanced malignant melanoma: a systematic review and health economic decision model in a Norwegian setting. | 2017 | Pharmacology and Therapeutics |
Risk of treatment-related mortality in cancer patients treated with ipilimumab: a systematic review and meta-analysis. | 2017 | European Journal of Cancer |
Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review. | 2017 | Expert Review of Anticancer Therapy |
Treatment-related death in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. | 2017 | Clinical Oncology |